Mature Woman
Old Asian Man
Smiling Young Man
Smiling Mature Man
Happy Man

ACCLINATE GENETICS

Diversifying Genomic Research & Clinical Trials

We are a trusted digital health company educating and engaging diverse individuals to make informed decisions about genomic research and clinical trial participation.

 

WHAT WE DO

We help biopharmaceutical companies and contract research organizations increase the representation & diversity of their genomic research and clinical trials.

OUR APPROACH

We do this through e-DICT, which stands for Enhanced Diversity in Clinical Trials.

e-DICT is our HIPAA compliant platform utilizing machine learning and predictive analytics to automate the identification, education, engagement, and retention of willing & diverse genomic research and clinical trial participants. e-DICT works in conjunction with our network of trusted relationships. We create value by decreasing the overall cost of drug development, increasing the speed of drug approval, integrating with virtual clinical trials, and aiding in the discovery of new drugs.

Brainstorming_edited.jpg
 

OUR FOUNDERS

            Co-Founder

  Chief Development Officer

Co-Founder

Chief Executive Officer

 
 
 

OUR LOCATION

Opened in 2008, HudsonAlpha Institute for Biotechnology has become an international leader in genomics research and biotech education. HudsonAlpha leverages the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The state-of-the-art facilities bring together scientific researchers with entrepreneurs and educators. and fosters more than 40 diverse biotech companies on campus.

To learn more about HudsonAlpha, visit hudsonalpha.org

CONTACT US

We believe diversifying research increases knowledge about health issues and makes a difference in personalized healthcare for all. If you share our vision, we want to hear from you!

601 Genome Way, Suite 3400
Huntsville, AL 35806

256-435-2800

NEWS

ACCLINATE GENETICS IS THE LATEST ADDITION TO BRONZE VALLEY PORTFOLIO

Sep. 10, 2020

BIO ALABAMA ARTICLE "NEW CONVERSATIONS AROUND AN OLD PROBLEM"

Apr. 15, 2020

BIO ALABAMA ARTICLE "USING SPEECH AND DEBATE TO PROPEL AN IDEA FORWARD"

Apr. 15, 2020

ACCLINATE GENETICS WINS  LAUNCHPAD COMPETITION

Feb. 28, 2020

ACCLINATE SEEKS TO EDUCATE MINORITIES ON IMPORTANCE OF CLINICAL TRIALS

Sept. 5, 2019

ACCLINATE GENETICS WORKS TO FIGHT HEALTH DISPARITIES

Aug. 28, 2019

ACCLINATE  WANTS MINORITIES REPRESENTED IN CLINICAL RESEARCH

Aug. 9, 2019

HEALTH DISPARITIES IN AFRICAN AMERICAN COMMUNITY RESURFACE AMID COVID-19

Apr. 15, 2020

ACCLINATE WORKING TO ADDRESS HEALTHCARE DISPARITIES

 Apr. 14, 2020

ACCLINATE PARTNERS WITH NATIONAL HBCU SPEECH & DEBATE

 Mar. 22, 2020

ACCLINATE TEAMS WITH GOVERNOR'S OFFICE OF MINORITY AFFAIRS

Oct. 28, 2019

HUNTSVILLE COMPANY ON A MISSION TO TRANSFORM THE STATUS QUO OF CLINICAL RESEARCH

Aug. 12, 2019

ALABAMA-BASED GENETIC RESEARCH FIRM AT FOREFRONT TO DRIVE DIVERSE CLINICAL TRIAL PARTICIPATION

Aug. 10, 2019

MANAGEMENT SYSTEM AIMS TO ENHANCE DIVERSITY IN US CLINICAL TRIALS

Aug. 12, 2019

instagramicon.png
facebookicon12_edited_edited.png
twittericon1.webp
youtube icon.png

©2019 by Acclinate Genetics